Literature DB >> 2624434

Urinary oestrogen excretion after the menopause in relation to age and body mass.

P A Mole1, M H Rae, C R Paterson.   

Abstract

We have measured urinary excretion of free immunoreactive oestrone and oestradiol and their respective glucuronides in relation to creatinine in early morning samples in 132 fit, active postmenopausal women. None of the oestrogen/creatinine ratios was significantly correlated either with age or with years since menopause. However, we did demonstrate significant positive correlations between the levels of all four oestrogens and the body mass index, weight and fat mass. These results are similar to those obtained by other workers for plasma or serum oestrogen levels. Since assessment of oestrogenic status from plasma or serum may call for several samples to allow for the rapid minute-to-minute variation in levels, urinary oestrogenic assays as described may provide a valuable non-invasive measurement of oestrogenic status. Such measurements may have a place in the identification of women at greater risk of developing symptomatic osteoporosis in later life.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624434     DOI: 10.1159/000177541

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  3 in total

1.  Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause.

Authors:  M H Walkinshaw; P A Mole; C R Paterson
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

2.  Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women.

Authors:  R W Keen; T Nguyen; R Sobnack; L A Perry; P W Thompson; T D Spector
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Association between urine and serum estradiol levels in in vitro fertilization cycles.

Authors:  Chokchai Chotboon; Lingling Salang; Pranom Buppasiri; Siriruthai Amnatbuddee; Nuntasiri Eamudomkarn
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.